The global peptide synthesis market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period. High prevalence of chronic diseases such as cancer, diabetes, and obesity globally is boosting the market as peptides are being used in the treatment of these diseases. For instance, According to international diabetes federation, it is anticipated that the number of diabetes patients will rise to 643 million by 2030 and 541 million are at high risk of type 2 diabetes. Various peptide therapies are popular for treatment of type 2 diabetes. Furthermore, according to the national center for biotechnology information, it is anticipated that there will be 26 million rises in cancer patients by 2030 and 17 million deaths by cancer due to growth of population. Thus, the demand for peptides due to increasing prevalence is expected to rise, which will boost the market growth.
The increasing mergers and acquisition in the market are further supporting in the market growth. For instance, in October 2021, Biotage AB acquired ATDBio Ltd through a partnership agreement for approximately GBP 45m in cash and shares. The acquisition, which provides Biotage with expertise in highly complex DNA and RNA production, will allow accelerated expansion of the UK company’s activities.
To Request a Sample of our Report on Peptide Synthesis Market: https://www.omrglobal.com/request-sample/peptide-synthesis-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Technology
- By Product and Services
- By End-user
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corp., Bachem Holding AG, AAPPTec, Gyros Protein Technologies, Vivitide, Advanced ChemTech, Syngene International Ltd., Lonza Group Ltd. and others.
A full Report of Peptide Synthesis Market is Available @ https://www.omrglobal.com/industry-reports/peptide-synthesis-market
Peptide Synthesis Market Segmentation
By Technology
- Solid Phase
- Liquid Phase
- Hybrid and Recombinant
By Product
- Equipment
- Reagents
- Consumables
- Others
By End-User
- Pharmaceutical& Biotechnology Companies
- Contract Development & Manufacturing Organizations
- Academic and Research Institutes
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- AAPPTec
- CSBio
- CEM Corp.
- Biotage AB
- JPT Peptide Technologies
- Gyros Protein Technologies
- Advanced ChemTech
- Creative Diagnostics, Inc
- PolyPeptide Group
- Syngene International Ltd.
- Purolite Corp.
- Lonza Group Ltd.
- MP Biomedicals, LLC
- Novo Nordisk A/S
- Vivitide
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/peptide-synthesis-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
